Sign in
4

Changes in Ownership

Adaptimmune Therapeutics PLC Filed Acc 0001104659-23-097853

Chief Executive Officer sold 2,403 shares at $0.78 ($1,874)

From the SEC's structured data for this filing

Trades in this filing

Rawcliffe Adrian · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-09-01 Sale : show line 1 in the form −2,403 $0.78 $1,874 3,449 D
Open-market sales · 2,403 sh · avg $0.78 · $1,874
Loading xslF345X05/tm2325388-1_4seq1.xml…